BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.
BioNxt Solutions Stock Performance
Shares of OTCMKTS:BNXTF opened at $0.30 on Friday. BioNxt Solutions has a twelve month low of $0.14 and a twelve month high of $0.80. The firm has a market cap of $36.39 million, a PE ratio of -7.43 and a beta of 0.69. The business has a fifty day moving average of $0.35 and a 200-day moving average of $0.42.
BioNxt Solutions Company Profile
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Read More
- Five stocks we like better than BioNxt Solutions
- MarketBeat Week in Review – 05/25 – 05/29
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
